Follow this innovation
[ via 
] [?]
Endometriosis Marker
University of Missouri System: University of Missouri-Columbia
posted on 06/24/2011
Endometriosis is a condition manifested by pelvic pain that is estimated to affect 10 – 15% of women in their reproductive years. The pain is caused by endometrial-like cells flourishing outside of the uterine cavity and responding to the hormonal changes occurring throughout the menstrual cycle. It is important to diagnose endometriosis not only so that it can be treated correctly, but because endometriosis may cause scarring of the tissue and infertility, and to rule out endometrial cancer and other causes of abdominal pain.
The current invention developed by researchers at the University of Missouri is a marker protein for the diagnosis of endometriosis. ENDO I (haptoglobin) was found at elevated levels in the cells causing endometriosis while being absent from endometrial cancer cells.
Suggested Uses
- Diagnosis of endometriosis
- Monitoring treatment of endometriosis
Advantages
- Histochemical staining of tissue can be used to distinguish between endometriosis and endometrial cancer
- Can be included in a biomarker panel
Detailed Description
STATE OF DEVELOPMENT
Ready to use
LICENSING POTENTIAL
University seeks licensee with potential to commercialize
File Number: 94UMC023
Disease: Women's Health
Other Information:
TECHNOLOGY INNOVATORS
Kathy L. Timms
TECHNOLOGY MANAGER CONTACT
Harriet F. Francis, MS, JD
Senior Licensing Associate
Email: francish@missouri.edu
Phone: 573-884-0374
This innovation currently is not available for online licensing. Please contact Harriet Francis at University of Missouri Office of Technology and Industry Relations for more information.
| Patent Number(s): | 7122322 |
|---|
This innovation currently is not available for online licensing. Please contact Harriet Francis at University of Missouri System: University of Missouri-Columbia for more information.
request more info
ProfileFind more innovations
